Tag

Srinivas Sadu

1 article

Gland Pharma Q4 FY26 Revenue Up 22% YoY

Gland Pharma reported Q4 FY26 revenue of INR17,428 million, a 22% YoY growth, with adjusted EBITDA at INR5,244 million (30% margin). Full-year FY26 revenue reached INR64,307 million (14.5% growth), wi